| Mrs Julie B Fortenberry, MCD, CCC-A | |
|
1948 Alabama Hwy 157, Suite 410, Cullman, AL 35058-0643 | |
| (256) 737-0368 | |
| (256) 734-9530 |
| Full Name | Mrs Julie B Fortenberry |
|---|---|
| Gender | Female |
| Speciality | Qualified Audiologist |
| Experience | 25 Years |
| Location | 1948 Alabama Hwy 157, Cullman, Alabama |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124278080 | NPI | - | NPPES |
| 118010 | Medicaid | AL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | 1007A (Alabama) | Primary |
| 237600000X | Audiologist-hearing Aid Fitter | 1007A (Alabama) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ent Associates Of Alabama, P.c. | 8921025354 | 34 |
News Archive
The most frequent reason pediatricians prescribe antibiotics to young children is for an ear infection (acute otitis media). With increased concerns about high rates of antibiotic use and resistance, recent guidelines suggest consideration of "watchful waiting" for some ear infections to see if they resolve without antibiotics.
The first national outcome-based contract between a pharmaceutical company and a pharmacy benefit management company resulted in an increase in the number of people with type 2 diabetes who were able to control their blood sugar levels by taking their medications appropriately.
A new modeling framework designed to track the transmission of severe acute respiratory syndrome coronavirus (SARS-CoV-2) in the U.S. suggests that the coronavirus disease 2019 (COVID-19) epidemic was not under control by the end of May - just before containment measures were relaxed.
AMAG Pharmaceuticals, Inc. today announced that it has submitted a supplemental new drug application (sNDA) to the United States Food and Drug Administration (FDA) for Feraheme (ferumoxytol) Injection for Intravenous (IV) use.
› Verified 1 days ago
| Provider Name | Ent Associates Of Alabama, P.c. |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1841301082 PECOS PAC ID: 8921025354 Enrollment ID: O20051025001005 |
News Archive
The most frequent reason pediatricians prescribe antibiotics to young children is for an ear infection (acute otitis media). With increased concerns about high rates of antibiotic use and resistance, recent guidelines suggest consideration of "watchful waiting" for some ear infections to see if they resolve without antibiotics.
The first national outcome-based contract between a pharmaceutical company and a pharmacy benefit management company resulted in an increase in the number of people with type 2 diabetes who were able to control their blood sugar levels by taking their medications appropriately.
A new modeling framework designed to track the transmission of severe acute respiratory syndrome coronavirus (SARS-CoV-2) in the U.S. suggests that the coronavirus disease 2019 (COVID-19) epidemic was not under control by the end of May - just before containment measures were relaxed.
AMAG Pharmaceuticals, Inc. today announced that it has submitted a supplemental new drug application (sNDA) to the United States Food and Drug Administration (FDA) for Feraheme (ferumoxytol) Injection for Intravenous (IV) use.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Julie B Fortenberry, MCD, CCC-A 833 Saint Vincents Dr, Suite 402, Birmingham, AL 35205-1606 Ph: (205) 933-9236 | Mrs Julie B Fortenberry, MCD, CCC-A 1948 Alabama Hwy 157, Suite 410, Cullman, AL 35058-0643 Ph: (256) 737-0368 |
News Archive
The most frequent reason pediatricians prescribe antibiotics to young children is for an ear infection (acute otitis media). With increased concerns about high rates of antibiotic use and resistance, recent guidelines suggest consideration of "watchful waiting" for some ear infections to see if they resolve without antibiotics.
The first national outcome-based contract between a pharmaceutical company and a pharmacy benefit management company resulted in an increase in the number of people with type 2 diabetes who were able to control their blood sugar levels by taking their medications appropriately.
A new modeling framework designed to track the transmission of severe acute respiratory syndrome coronavirus (SARS-CoV-2) in the U.S. suggests that the coronavirus disease 2019 (COVID-19) epidemic was not under control by the end of May - just before containment measures were relaxed.
AMAG Pharmaceuticals, Inc. today announced that it has submitted a supplemental new drug application (sNDA) to the United States Food and Drug Administration (FDA) for Feraheme (ferumoxytol) Injection for Intravenous (IV) use.
› Verified 1 days ago
Mrs. Jennifer Parker Burnham, MS,CCC-A Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1948 Al Highway 157, Suite 410, Cullman, AL 35058 Phone: 256-737-0368 |